TWST — Twist Bioscience Share News
0.000.00%
- $9.58bn
- $9.41bn
- $376.57m
U.S. STOCKS ON THE MOVE-Icahn Enterprises, Lyft, Western Alliance Bancorp
Twist Bioscience Corp reports results for the quarter ended in March - Earnings Summary
Twist Bioscience falls on lowering FY revenue outlook; announces job cuts
Brief: Twist Bioscience Expects Strategic Restructuring Plan To Be Implemented Beginning In Q3 Fiscal Year
Brief: Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
Twist Bioscience Corp expected to post a loss of $1.12 a share - Earnings Preview
Brief: Twist Bioscience Launches Tcr And Car Libraries To Enable The Development Of Cell Therapies
Brief: Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro and In Silico Approaches
Brief: Twist Bioscience Announces Technology Early Access Of Enhanced Whole Genome Sequencing Solution At AGBT
U.S. STOCKS ON THE MOVE-Energy index, Church & Dwight, Personalis
Twist Bio falls after downbeat revenue forecast for Q2
Twist Bioscience Corp reports results for the quarter ended in December - Earnings Summary
Brief: Twist Bioscience Reports Fiscal First Quarter 2023 Results
Brief: Twist Bioscience Sees Q2 revenue $56.5 million
Twist Bioscience Corp expected to post a loss of $1.13 a share - Earnings Preview
Twist Bioscience up on antibody discovery research deal with Astellas
Brief: Twist Bioscience, Astellas Collaborates For Multitarget Antibody Discovery Research
Refile: BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Starbucks, ASLAN Pharma
U.S. STOCKS ON THE MOVE-Jasper Therapeutics, Blackstone, Mondelez